- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2009
- Public Summary Document (PSD) July 2009 PBAC Meeting - PDF
Cetuximab – July 2009
Cetuximab, solution for I.V. infusion, 100 mg in 20 mL, 100 mg in 50 mL and 500 mg in 100 mL, Erbitux®
Last updated
30 October 2009